ipilimumab,nivolumab,durvalumab,paclitaxel,vinorelbine,carboplatin,cisplatin,gemcitabine,docetaxel,pemetrexed
bms,astrazeneca
['cm816']
 yes, new option, but is there anyone in whom you would say you (or anyone) should favor it over cm816? particularly when you start treatment w/o knowing if pt will achieve pcr or not later? we say "nice, another option" as if there's any value in having &gt;1. it costs $200k more!
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website